Author Question: Which of the following will be most beneficial to Maximus if it builds a manufacturing facility in ... (Read 49 times)

V@ndy87

  • Hero Member
  • *****
  • Posts: 571
Which of the following will be most beneficial to Maximus if it builds a manufacturing facility in India, which is an emerging market with a large manufacturing base?
 
  A) legal precedents
  B) high-quality labor pool
  C) government regulations
  D) solid infrastructures

Question 2

In a short essay, provide examples of poor physical infrastructures.
 
  What will be an ideal response?



sylvia

  • Sr. Member
  • ****
  • Posts: 331
Answer to Question 1

Thanks for your help Worked like a charm.

Answer to Question 2

In emerging markets, high-quality roads, drainage systems, sewers, and electrical utilities are often sorely lacking. Industrial cities like Bangalore and Pune in India regularly experience power outages that can last 24 hours or more. A subsidiary of Tata Chemicals, part of India's giant Tata conglomerate, had to build its own road and railway infrastructures in Africa to support the firm's operations there.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Essential fatty acids have been shown to be effective against ulcers, asthma, dental cavities, and skin disorders such as acne.

Did you know?

On average, the stomach produces 2 L of hydrochloric acid per day.

Did you know?

The lipid bilayer is made of phospholipids. They are arranged in a double layer because one of their ends is attracted to water while the other is repelled by water.

Did you know?

In the United States, congenital cytomegalovirus causes one child to become disabled almost every hour. CMV is the leading preventable viral cause of development disability in newborns. These disabilities include hearing or vision loss, and cerebral palsy.

Did you know?

Fatal fungal infections may be able to resist newer antifungal drugs. Globally, fungal infections are often fatal due to the lack of access to multiple antifungals, which may be required to be utilized in combination. Single antifungals may not be enough to stop a fungal infection from causing the death of a patient.

For a complete list of videos, visit our video library